Search research articles
Contact Us
Filters
Showing results (561-570 of 751) with videos related to
Page
of 76
Sort By:
International Journal of Cardiology
|
February 15, 2020
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
David Brieger, Stuart J Pocock, Stefan Blankenberg, et al.
European Heart Journal
|
April 14, 2017
Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials
Ioanna Kosmidou, Björn Redfors, Harry P Selker, et al.
Contemporary Clinical Trials Communications
|
February 1, 2024
Evaluating registry-based trial economics: Results from the STRESS clinical trial
Eric L Eisenstein, Kevin D Hill, Nancy Wood, et al.
Critical Pathways in Cardiology
|
March 15, 2008
Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries
Benjamin M Scirica, Christopher P Cannon, C Michael Gibson, et al.
The Canadian Journal of Cardiology
|
January 22, 2025
Differences in Care and Outcomes in Cardiogenic Shock in Cardiac Intensive Care Units in the United States and Canada: CCCTN Registry Insights
Madeleine Barker, Sean van Diepen, Christopher B Granger, et al.
American Heart Journal
|
March 10, 2010
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale
Renato D Lopes, John H Alexander, Sana M Al-Khatib, et al.
JAMA Cardiology
|
February 27, 2020
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis
Renato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.
Journal of the American College of Cardiology
|
November 12, 2013
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)
Greg Flaker, Renato D Lopes, Sana M Al-Khatib, et al.
Circulation
|
July 18, 2002
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes
Sana M Al-Khatib, Christopher B Granger, Yao Huang, et al.
Clinical Cardiology
|
November 4, 2020
Diabetes association with self-reported health, resource utilization, and prognosis post-myocardial infarction
José C Nicolau, David Brieger, Ruth Owen, et al.
Page
of 76
Search research articles
Search
Showing results (561-570 of 751) with videos related to
Sort By:
Page
of 76
International Journal of Cardiology
|
February 15, 2020
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
David Brieger, Stuart J Pocock, Stefan Blankenberg, et al.
European Heart Journal
|
April 14, 2017
Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials
Ioanna Kosmidou, Björn Redfors, Harry P Selker, et al.
Contemporary Clinical Trials Communications
|
February 1, 2024
Evaluating registry-based trial economics: Results from the STRESS clinical trial
Eric L Eisenstein, Kevin D Hill, Nancy Wood, et al.
Critical Pathways in Cardiology
|
March 15, 2008
Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries
Benjamin M Scirica, Christopher P Cannon, C Michael Gibson, et al.
The Canadian Journal of Cardiology
|
January 22, 2025
Differences in Care and Outcomes in Cardiogenic Shock in Cardiac Intensive Care Units in the United States and Canada: CCCTN Registry Insights
Madeleine Barker, Sean van Diepen, Christopher B Granger, et al.
American Heart Journal
|
March 10, 2010
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale
Renato D Lopes, John H Alexander, Sana M Al-Khatib, et al.
JAMA Cardiology
|
February 27, 2020
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis
Renato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.
Journal of the American College of Cardiology
|
November 12, 2013
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)
Greg Flaker, Renato D Lopes, Sana M Al-Khatib, et al.
Circulation
|
July 18, 2002
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes
Sana M Al-Khatib, Christopher B Granger, Yao Huang, et al.
Clinical Cardiology
|
November 4, 2020
Diabetes association with self-reported health, resource utilization, and prognosis post-myocardial infarction
José C Nicolau, David Brieger, Ruth Owen, et al.
Page
of 76